Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study-Reference-Cited by-同舟云学术

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Published:2009-03 Issue:3 Volume:10 Page:223-232
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Fenaux Pierre,Mufti Ghulam J,Hellstrom-Lindberg Eva,Santini Valeria,Finelli Carlo,Giagounidis Aristoteles,Schoch Robert,Gattermann Norbert,Sanz Guillermo,List Alan,Gore Steven D,Seymour John F,Bennett John M,Byrd John,Backstrom Jay,Zimmerman Linda,McKenzie David,Beach CL,Silverman Lewis R

Publisher

Elsevier BV

Subject

Oncology

Reference38 articles.

1. Myelodysplastic syndromes: introduction;Sloand;Semin Hematol,2008

2. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference;Valent;Leuk Res,2007

3. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol,1982

4. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997;Harris;J Clin Oncol,1999

5. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

Cited by 2288 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of treatment-related myelodysplastic syndrome in the early stage after radiotherapy in a patient with cancer of the oral floor;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2024-11

2. Research hotspots and trends of epigenetic therapy in oncology: a bibliometric analysis from 2004 to 2023;Frontiers in Pharmacology;2024-09-12

3. SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2024-09

4. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

5. Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia;Leukemia Research;2024-09